Clinical Trial Update: Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating naltrexone/bupropion for methamphetamine use disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder

Drugs mentioned

• Naltrexone (Naltrexone)
• bupropion (bupropion)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Methamphetamine-dependence, Methamphetamine Abuse | Phase 3 | Status: RECRUITING